The Dutch government has shown some interest in changing the way we let the pharmaceutical industry capture biomedical knowledge for profit. Several political parties have started to engage with civil society to design alternative systems. There are now a number of non-profit medicine producers emerging in The Netherlands. More and more pharmacies are engaging in some sort of compounding. In short, The Netherlands offers opportunities for Commons Network and other civil society actors to explore, develop and promote alternative systems.